Chronic Disease Management: Therapeutics, Device Technologies and Global Markets, 2020-2021 & 2026
DUBLIN, April 25, 2022 /PRNewswire/ -- The "Chronic Disease Management: Therapeutics, Device Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.
Chronic disease management includes numerous drugs and medical device-based techniques used for the management of various chronic diseases. This report is an analytical business tool with the primary purpose of providing a thorough evaluation of the global market for chronic disease management through various therapeutics and advanced device technologies.
The report will provide detailed exposure to chronic disease management market. This report analyzes the market trends of chronic disease management with data from 2020, estimates from 2021, projections of compound annual growth rates through 2026 (forecast period 2021 - 2026), and regional markets of the chronic disease management.
This report will highlight the current and future market potential of chronic disease management along with a detailed analysis of the competitive environment. Regulatory scenario, drivers, restrains, and opportunities will be covered in the current report. The report also covers market projections for 2026, and market Shares of key market players.
The regional market analysis of chronic disease management is also covered in this report. The market has been segmented into various major regions including North America, Europe, Asia-Pacific, and rest of world regions. Detailed analysis of major countries such as the U.S., Germany, the U.K., Italy, France, Japan, China, and India are going to be covered within the regional segment. For market estimates, data are going to be provided for 2020 because the base year, with estimates for 2021 and forecast value for 2026.
The Report Includes:
An up-to-date review and analysis of the global market for chronic disease management therapeutics and device technologies
Analyses of the global market trends, with data from 2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026
Evaluation and forecast the overall market size, forecasted growth trends, and corresponding market share analysis by product category, disease type, delivery technology, treatment adherence, treatment provider, and region
Insight into the current state of chronic diseases and disorders, with an emphasis on advance needle-free drug delivery technologies, diagnostic methods, and smart device technologies that support effective disease state management
Regulatory structure for pharmaceuticals and medical devices, pricing and reimbursement structure, marketed and pipeline products, and major developments influencing the market
Key merger and acquisition deals, development of commercially viable products and technologies, and other strategic alliances within the industry
Profile descriptions of the leading global players including Abbott, AbbVie Inc., Amgen Inc., Bayer AG, Boston Scientific Corp., Dr. Reddy's Laboratories Ltd., F. Hoffmann, GlaxoSmithKline PLC, Johnson & Johnson, Medtronic, Novartis, Sanofi, Pfizer and Takeda
Company Profiles
Abbott
Abbvie Inc.
Acadia Pharmaceutical
Acorda Therapeutics
Adherium
Agenus
Akron
Alivecor
Alkermes
Amgen Inc.
Amiko
Amneal Pharmaceuticals
Anavex Life Sciences
Ani Pharmaceuticals
Apotex
Arena Pharmaceuticals
Asahi Kasai Corp.
Aslan Pharmaceuticals
Aspen Pharmacare
Astellas Pharma Inc.
Astrazeneca
Athersys
Axsome Therapeutics
Bausch Health Companies Inc.
Bayer AG
Beigene
Biosensics
Bioserenity
Biotricity
Biotronik
Bioxcel Therapeutics
Boehringer Ingelheim International GmbH
Boston Scientific Corporation
Bristol-Myers Squibb
BTS Bioengineering
Chugai Pharmaceuticals Co. Ltd.
Cipla
Clovis Oncology
Connectedhealth Pte. Ltd.
Corbus Pharmaceuticals
Cspc Pharmaceutical Group
Daiichi Sankyo
Dr. Reddy'S Laboratories Ltd.
Earlysense
Edwards Lifesciences Corp.
Eli Lilly
Empatica
Endo International
Endoceutics Inc.
Erytech Pharma
Esteve
Everist Health
F. Hoffmann-La Roche Ltd.
Gilead Sciences Inc.
GlaxoSmithKline plc
Glooko Inc.
Halozyme Therapeutics
Hikma Pharmaceuticals
Hocoma
Ihealth
Infobionic Inc.
Insulet Corp.
Intelesens
Intra-Cellular Therapies
Iovance Biotherapeutics
Ipsen S.A.
Jan Medical Inc.
Jiangsu Hengrui Medicine
Johnson & Johnson Services Inc.
Kyowa Hakko Kirin
Les Laboratoires Servier
Lundbeck
Lupin
Mallinckrodt plc
Medminder
Medtronic Inc.
Menarini
Merck Kgaa
Mitsubishi Tanabe Pharma
Nemaura Medical Inc.
Neofect Co. Ltd.
Neurocrine Biosciences
Neurometrix Inc.
Novartis AG
Novo Nordisk
Nucana
Omada Health Inc.
Omnicell Inc.
Omron Corp.
Ono Pharmaceutical Co. Ltd.
Orion Pharma Ltd.
Otsuka Holdings Co. Ltd.
Pacira Pharmaceuticals Inc.
Pfizer Inc.
Philosys
Polar Electro Oy
Prescribewellness LLC
Preventice Inc.
Propeller Health
Qardio
Rehab-Robotics (A Member of Vincent Medical Holdings)
Sage Therapeutics
Sanofi S.A.
Sarepta Therapeutics
Sense4Care
Shanghai Pharmaceuticals Holding
Shionogi and Co. Ltd.
Stada Arzneimittel AG
Sumitomo Dainippon Pharma Co. Ltd.
Sun Pharmaceutical Industries
Taisho Pharmaceutical
Takeda Pharmaceutical Company Ltd.
Tcr2 Therapeutics
Teva Pharmaceuticals Industries Ltd.
Tyme Technologies
Vertex Pharmaceutical
Viatris Inc.
Vital Connect
West Pharmaceutical Services Inc.
Winmedical Srl
Ypsomed Holding AG
Zogenix Inc.
Zydus Cadila
For more information about this report visit https://www.researchandmarkets.com/r/7cur39
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716
View original content:https://www.prnewswire.com/news-releases/chronic-disease-management-therapeutics-device-technologies-and-global-markets-2020-2021--2026-301531762.html
SOURCE Research and Markets